islet cell autoantibody
Recently Published Documents
2016 ◽
Vol 462
◽
pp. 60-64
◽
Marie Amoroso
◽
Peter Achenbach
◽
Michael Powell
◽
Rebecca Coles
◽
Monika Chlebowska
◽
...
2007 ◽
Vol 24
(11)
◽
pp. 1221-1228
◽
R. Jensen
◽
L. Gilliam
◽
C. Torn
◽
M. Landin-Olsson
◽
J. Palmer
◽
...
2007 ◽
Vol 40
(7)
◽
pp. 540-545
◽
Luis Sarmiento
◽
Eduardo Cabrera-Rode
◽
Lister Lekuleni
◽
Ileana Cuba
◽
Gisela Molina
◽
...
2003 ◽
Vol 26
(2)
◽
pp. 452-457
◽
N. Hosszufalusi
◽
A. Vatay
◽
K. Rajczy
◽
Z. Prohaszka
◽
E. Pozsonyi
◽
...
2002 ◽
Vol 51
(5)
◽
pp. 1346-1355
◽
J. Graham
◽
W. A. Hagopian
◽
I. Kockum
◽
L. S. Li
◽
C. B. Sanjeevi
◽
...
Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus1Abbreviations: s.c., subcutaneous; i.p., intraperitoneal; i.v., intravenous; IFA, incomplete Freund's adjuvant; DTP, diphtheria-tetanus-pertussis; LCMV, lymphocytic choriomeningitis virus; GAD, glutamic acid decarboxylase; ICA, islet cell autoantibody; JDF, juvenile diabetes foundation; IAA, insulin autoantibody; GAA, glutamic acid decarboxylase autoantibody; DM, diabetes mellitus; RIA, radioimmunoassay; AA, autoantibody; kD, kilodalton; FPIR, first phase insulin release; IIF, indirect immunofluoresence; IGT, impaired glucose tolerance; OGT, oral glucose tolerance.1
1999 ◽
Vol 35
(2-3)
◽
pp. 143-156
◽
Patricia M. Graves
◽
George S. Eisenbarth
1997 ◽
Vol 208
(2)
◽
pp. 169-179
◽
Maris Rulli
◽
Ari Kuusisto
◽
Juha Salo
◽
Hannu Kojola
◽
Olli Simell
1997 ◽
Vol 46
(9)
◽
pp. 1459-1467
◽
M. Fuchtenbusch
◽
K. Ferber
◽
E. Standl
◽
A.-G. Ziegler
1997 ◽
Vol 46
(9)
◽
pp. 1459-1467
◽
M. Fuchtenbusch
◽
K. Ferber
◽
E. Standl
◽
A. G. Ziegler
1990 ◽
Vol 33
(9)
◽
pp. 569-572
◽
C. Y. Pak
◽
C. Y. Cha
◽
R. V. Rajotte
◽
R. G. McArthur
◽
J. W. Yoon